ArticleCancers2026

Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study.

Itika Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.